This is a past event. Registration is closed. View other The Swedish Chamber of Commerce in China events.
As COVID-19 continues its spread around the world, pharmaceutical companies have been working day and night for their shared goal: to develop a vaccine against the disease and end the pandemic.
AstraZeneca, a global pharmaceutical company combining Swedish and British innovation, is at the forefront of vaccine development. They announced on November 23rd that their vaccine is up to 90% effective. With this significant progress, they will hopefully soon be able to provide the world with a safe and reliable vaccine. 💉
SwedCham is proud to welcome Alec van Gelder, Executive Director of International Government Affairs at AstraZeneca in Shanghai, for this final Sharp Talk of 2020. He will present to us AstraZeneca's journey and progress on vaccine development, unique insights from a pharmaceutical company operating in a pandemic world, and their determination to make the vaccine accessible for all and at no profit during the pandemic.
This event is a hybrid event and you are welcome to join us offline in Shanghai at address below, or online on Zoom. We are very happy to partner with the Swedish Chambers in several APAC countries and their members will also join online!
What?
Sharp Talk: Vaccine Development with AstraZeneca
When?
December 15th
08:30-10:00 AM
Where?
Venue sponsored by:
M Place, China Merchants Plaza
333 Chengdu North Road, 9/F, Room 903
For online attendance, please register Zoom ticket.
About the speaker
Alec van Gelder is a Public Affairs leader, with experience managing high level stakeholders and influencing public policy globally, particularly in emerging markets, including China. He joined AstraZeneca in 2011.
Speakers
Alec van Gelder
Executive Director, International Government Affairs of AstraZeneca China
More Information
Alec
van Gelder
Executive Director, International Government Affairs of AstraZeneca China
Alec van Gelder is Executive Director, International Government Affairs for AstraZeneca. In this role, Alec leads the Region to drive national and regional priorities and supports regional strategic initiatives that enable AZ to establish closer partnerships with governments.
Alec joined AstraZeneca in 2011 as Global Director for Public Policy in the UK. He has also held roles as Director of Access and Affordability establishing and leading AstraZeneca’s flagship Healthy Heart Africa program.
Prior to joining AZ, Alec was Policy Director for International Policy Network in the UK. Alec holds a Master’s degree in Economics from University de Louvain-la-Neuve in Belgium and a Finance Degree from Lehigh University in the USA.
Sponsors and Partners
Corporate Gold Partners
A special thanks to our Corporate Gold Partners for supporting the Swedish business community in China.
